Regular Non-steroidal Anti-inflammatory Drug Use Increases Stress Fracture Risk in the General Population: A Retrospective Case-Control Study

Author:

Ciuciu AlexandraORCID,Mulholland Christopher,Bozzi Michael A.,Frymoyer Chris C.,Cavinatto Leonardo,Yaron David,Harwood Marc I.,Close Jeremy D.,Mehallo Christopher J.,Tomlinson Ryan E.

Abstract

ABSTRACTPrevious studies have shown that the use of non-steroidal anti-inflammatory drugs (NSAIDs) is associated with increased stress fracture risk, potentially due to diminished skeletal adaptation. This phenomenon has been studied predominantly in high-activity individuals like dancers, athletes, and soldiers, so current data regarding the general population is limited despite the substantial economic and resource burden of stress fracture injuries within the general US population. Furthermore, our preclinical studies demonstrate that regular use of NSAIDs also diminishes the intrinsic ability of bone to resist fracture. To determine the association of regular NSAID use with stress fractures in the general population, we surveyed subjects presenting with either stress fracture or uncomplicated ankle sprain to assess their use of NSAIDs over the three months before their injury. We hypothesized that subjects with stress fractures would have increased regular NSAID usage as compared to controls. Subjects diagnosed with a stress fracture (n=56) and subjects with uncomplicated ankle sprains (n=51; control) were surveyed about their NSAID use at the time of their diagnosis and in the previous three months using a questionnaire based on the National Health and Nutrition Examination Survey (NHANES). Subjects were surveyed in person on the day of their injury diagnosis or by phone within 30 days of their injury diagnosis. Fisher’s exact test was used to determine significant differences in NSAID usage between stress fracture and control subjects. Subjects diagnosed with stress fractures had a statistically significant increase in both current use (p=0.03) and regular use (p=0.04) of ibuprofen/naproxen/celecoxib as compared to control subjects. There were no significant differences in the use of aspirin, acetaminophen, or prescription medications containing acetaminophen between groups. Consistent with previous clinical reports, we observed a strong correlation between regular ibuprofen/naproxen/celecoxib use and stress fracture incidence in the general population. These results indicate that any patients at high risk for stress fracture should avoid regular use of ibuprofen, naproxen, or celecoxib.KEY POINTSThis retrospective case-control study found that use of ibuprofen, naproxen, and/or celecoxib by subjects within the general population three or more times per week for three months (regular use) was highly associated with stress fracture diagnosis.No significant correlation between stress fracture diagnosis and the use of acetaminophen, aspirin, or prescription drugs containing acetaminophen was found.Pooled analysis of all surveyed drugs indicated a strong association between stress fracture diagnosis and NSAID or acetaminophen usage in the general population, consistent with previous work done in US Army soldiers and athletes.Due to the differences in mechanisms of action of the drugs surveyed in this study, future work is needed to conclude which NSAID, if any, is safest for regular use by those at higher risk of stress fracture formation.The findings of this study highlight the need for future studies to include subjects from the general population in addition to high-activity subjects as they indicate that these individuals are also at higher risk of stress fracture formation with regular NSAID use.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3